The principal objective of the T32 program """"""""Infectious Disease Training in Clinical Investigation"""""""" is to provide mentored research training that will prepare physician investigators for successful and productive academic careers in Infectious Diseases. The rationale for this program is that this field continues to witness enormous growth and new challenges due to emerging and re-emerging infections, both within the U.S. and globally, for which a new generation of well-trained clinical investigators is needed. To accomplish this goal, an interdisciplinary faculty from the University of Minnesota Medical School (and its Departments of Medicine, Pediatrics, and Microbiology), School of Public Health, College of Pharmacy, College of Dentistry, and College of Veterinary Medicine, as well as the Minnesota Department of Health, has been engaged in this training program. These faculty trainers have expertise in one or more of eight core topic areas relevant to emerging and re-emerging Infections: 1) HIV/AIDS, 2) Invasive Bacterial Infections, 3) Antimicrobial Resistance, 4) Immunodeficiency/Vaccines, 5) International and Immigrant Health, 6) Bioterrorism, 7) Foodborne Infections, and 8) Zoonoses. The program is designed for physicians who have completed an internal medicine or pediatrics residency program, plus at least one year of clinical training in adult or pediatric Infectious Diseases. It will support two years of focused, closely mentored research training in clinical and/or epidemiological research, as well as completion of the requirements for a Master of Public Health in Epidemiology or Master of Science in Clinical Research degree. The program will accept approximately two new trainees annually, giving a total of approximately four trainees in the program at any time.

Public Health Relevance

The relevance of this training program lies in the increasing threat to public health posed by emerging and re-emerging infections, as exemplified by community-associated methicillin-resistant Staphylococcus aureus, the HIV/AIDS epidemic, extensively-drug-resistant tuberculosis, E. coli 0157:H7 outbreaks, and pandemic and avian influenza. This has created a need for additional expert clinical researchers who can discover the causes of, and find remedies for these growing threats.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
Mcsweegan, Edward
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Minnesota Twin Cities
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Johnson, James R (2018) Confusion and Bacteriuria in Long-Term Care Facility Residents. J Am Geriatr Soc 66:1235
Bahr, Nathan C; Panackal, Anil A; Durkin, Michelle M et al. (2018) Cryptococcal meningitis is a cause for cross-reactivity in cerebrospinal fluid assays for anti-Histoplasma, anti-Coccidioides and anti-Blastomyces antibodies. Mycoses :
Diehl, John W; Hullsiek, Katherine H; Okirwoth, Michael et al. (2018) Cerebral Oximetry for Detecting High-mortality Risk Patients with Cryptococcal Meningitis. Open Forum Infect Dis 5:ofy105
Pragman, Alexa A; Lyu, Tianmeng; Baller, Joshua A et al. (2018) The lung tissue microbiota of mild and moderate chronic obstructive pulmonary disease. Microbiome 6:7
Bahr, Nathan C; Nuwagira, Edwin; Evans, Emily E et al. (2018) Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study. Lancet Infect Dis 18:68-75
Bahr, Nathan C; Halupnick, Ryan; Linder, Grace et al. (2018) Delta-like 1 protein, vitamin D binding protein and fetuin for detection of Mycobacterium tuberculosis meningitis. Biomark Med 12:707-716
Rhein, Joshua; Hullsiek, Kathy H; Evans, Emily E et al. (2018) Detrimental Outcomes of Unmasking Cryptococcal Meningitis With Recent ART Initiation. Open Forum Infect Dis 5:ofy122
Abassi, Mahsa; Rhein, Joshua; Meya, David B et al. (2018) Cryptococcal Disease in the Era of ""Test and Treat"": Is There Cause for Concern? Open Forum Infect Dis 5:ofx274
Lofgren, Sarah M; Nakasujja, Noeline; Boulware, David R (2018) Systematic Review of Interventions for Depression for People Living with HIV in Africa. AIDS Behav 22:1-8
Ellis, Jayne; Cresswell, Fiona V; Joshua, Rhein et al. (2018) Cryptococcal Meningitis and Tuberculous Meningitis Co-infection in HIV-Infected Ugandan Adults. Open Forum Infect Dis 5:ofy193

Showing the most recent 10 out of 85 publications